Lofepramine/Phenylalanine/Vitamin B12

洛非帕明/苯丙氨酸/维生素B12

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLofepramine/Phenylalanine/Vitamin B12
Drug Alias NameVitamin B12/Phenylalanine/Lofepramine苯丙氨酸/维生素B12/洛非帕明Phenylalanine/Vitamin B12/LofepramineVitamin B12/Lofepramine/PhenylalanineSC-124a
ClassificationSmall molecules
Mechanisms of ActionMethylmalonyl-CoA Mutase stimulantsMonoamine reuptake inhibitor
TargetsMethylmalonyl-CoA MutaseMonoamine transporters
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes CyanocobalaminLofepramine Hydrochloride
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotia
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A